Cargando…
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
OBJECTIVES: To investigate the eligibility for maintenance immunotherapy and its impact on the prognosis of advanced urothelial carcinoma treated with first‐line chemotherapy, as the selection biases of the eligible population in the JAVELIN Bladder 100 trial remain unclear. METHODS: We retrospectiv...
Autores principales: | Ozaki, Kai, Hatakeyama, Shingo, Tanaka, Toshikazu, Noro, Daisuke, Tokui, Noriko, Horiguchi, Hirotaka, Okuyama, Yoshiharu, Fujita, Naoki, Okamoto, Teppei, Okamoto, Akiko, Suzuki, Yuichiro, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988805/ https://www.ncbi.nlm.nih.gov/pubmed/35474727 http://dx.doi.org/10.1002/bco2.119 |
Ejemplares similares
-
Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer
por: Miura, Yuki, et al.
Publicado: (2021) -
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
por: Okuyama, Yoshiharu, et al.
Publicado: (2021) -
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021) -
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study
por: Ozaki, Yusuke, et al.
Publicado: (2023) -
Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers
por: Togashi, Kyo, et al.
Publicado: (2022)